Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Major histocompatibility complex class II deficiency].

M M Serrano-Martín1, D Moreno-Pérez, F J García-Martín

  • 1Unidad de Infectología e Inmunodeficiencias, Departamento de Pediatría, Hospital Materno-Infantil Carlos Haya, Málaga, España. mmarser@hotmail.com

Anales De Pediatria (Barcelona, Spain : 2003)
|March 14, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Recovering lost vaccine coverage due to COVID-19 pandemic].

Vacunas·2020
Same author

[Immunisation schedule of the Spanish Association of Paediatrics: 2016 recommendations].

Anales de pediatria (Barcelona, Spain : 2003)·2015
Same author

[Community acquired pneumonia in children: Treatment of complicated cases and risk patients. Consensus statement by the Spanish Society of Paediatric Infectious Diseases (SEIP) and the Spanish Society of Paediatric Chest Diseases (SENP)].

Anales de pediatria (Barcelona, Spain : 2003)·2015
Same author

[Immunisation schedule of the Spanish Association of Paediatrics: 2015 recommendations].

Anales de pediatria (Barcelona, Spain : 2003)·2015
Same author

[Community acquired pneumonia in children: Outpatient treatment and prevention].

Anales de pediatria (Barcelona, Spain : 2003)·2014
Same author

[Vaccination against meningococcal B disease. Public statement of the Advisory Committee on Vaccines of the Spanish Association of Paediatrics (CAV-AEP)].

Anales de pediatria (Barcelona, Spain : 2003)·2014

Major histocompatibility complex class II deficiency, a severe combined immunodeficiency, is most common in North Africa. Early diagnosis and bone marrow transplant are crucial for survival in affected infants.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Major histocompatibility complex (MHC) class II deficiency is a rare, autosomal recessive primary combined immunodeficiency.
  • It is characterized by a severe defect in cellular and humoral immunity.
  • Prevalence is notably higher in Mediterranean regions, particularly North Africa.

Observation:

  • This report details four cases of MHC class II deficiency.
  • The cases highlight the epidemiologic and clinical spectrum of the condition.
  • Diagnostic approaches, treatment strategies, and patient outcomes are described.

Findings:

  • MHC class II deficiency presents with high mortality within the first two years of life if undiagnosed.
  • Genetic basis involves defects in antigen presentation pathways.

Related Experiment Videos

  • Successful bone marrow transplantation offers a potential curative option.

    • Implications:

    • Emphasizes the critical need for early diagnosis of MHC class II deficiency in at-risk populations.
    • Highlights the importance of genetic counseling and timely intervention.
    • Underscores the potential of hematopoietic stem cell transplantation for treating this severe immunodeficiency.